Palo Alto Investors LP - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 166 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
Palo Alto Investors LP ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,951,000
+12.8%
652,3950.0%0.15%
+37.3%
Q4 2021$1,729,000
-27.0%
652,3950.0%0.11%
-23.1%
Q3 2021$2,368,000
-16.4%
652,3950.0%0.14%
-8.3%
Q2 2021$2,831,000
+26.9%
652,3950.0%0.16%
+22.8%
Q1 2021$2,231,000
-36.1%
652,395
-34.6%
0.13%
-30.6%
Q4 2020$3,494,000
+22.9%
998,156
-15.7%
0.18%
+17.3%
Q3 2020$2,842,000
-56.2%
1,184,092
-66.6%
0.16%
-59.9%
Q2 2020$6,483,000
+17.3%
3,542,5510.0%0.39%
-16.0%
Q1 2020$5,526,000
-27.1%
3,542,5510.0%0.46%
+11.0%
Q4 2019$7,581,000
+13.0%
3,542,551
-1.2%
0.42%
-6.7%
Q3 2019$6,708,000
-35.5%
3,587,351
-10.0%
0.45%
-11.7%
Q2 2019$10,403,000
+1.6%
3,985,9450.0%0.51%
+18.5%
Q1 2019$10,244,000
+11.7%
3,985,9450.0%0.43%
-12.5%
Q4 2018$9,168,000
-28.0%
3,985,945
+0.5%
0.49%
-5.2%
Q3 2018$12,731,000
+13.4%
3,966,0870.0%0.52%
+14.7%
Q2 2018$11,224,000
-20.1%
3,966,0870.0%0.45%
-25.2%
Q1 2018$14,040,000
-8.1%
3,966,087
+0.8%
0.60%
-8.8%
Q4 2017$15,270,000
+55.9%
3,935,584
+2.1%
0.66%
+59.7%
Q3 2017$9,792,000
-7.0%
3,855,0240.0%0.41%
-16.1%
Q2 2017$10,524,000
-25.3%
3,855,024
-9.4%
0.49%
-26.3%
Q1 2017$14,083,000
+41.7%
4,254,623
+1.9%
0.67%
+17.5%
Q4 2016$9,940,000
-47.8%
4,176,623
-19.5%
0.57%
-48.7%
Q3 2016$19,033,000
+58.4%
5,186,088
-3.7%
1.11%
+21.9%
Q2 2016$12,012,000
+10.4%
5,386,534
+3.0%
0.91%
+7.3%
Q1 2016$10,880,000
-31.5%
5,230,919
-0.2%
0.84%
-4.4%
Q4 2015$15,875,000
+24.2%
5,239,119
+1.2%
0.88%
+43.7%
Q3 2015$12,786,000
-23.1%
5,176,3190.0%0.62%
-16.8%
Q2 2015$16,616,000
-10.1%
5,176,3190.0%0.74%
-19.1%
Q1 2015$18,479,000
+57.3%
5,176,3190.0%0.91%
+32.5%
Q4 2014$11,750,000
+16.9%
5,176,319
-0.1%
0.69%
-8.1%
Q3 2014$10,049,000
-46.6%
5,180,1010.0%0.75%
-46.4%
Q2 2014$18,804,000
-53.1%
5,180,101
-49.9%
1.40%
-15.6%
Q1 2014$40,114,000
+169.8%
10,338,602
+98.2%
1.66%
+19.5%
Q4 2013$14,868,000
-34.1%
5,217,001
-17.2%
1.39%
-41.3%
Q3 2013$22,553,000
+71.6%
6,299,664
+60.1%
2.36%
+52.4%
Q2 2013$13,145,0003,935,5761.55%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders